New Report Just Published: Global Botulinum ToxinBusiness Wire (press release)... Solstice Neurosciences Inks Licensing Agreement with DreamPharma II-38 Botox Enters India Market II-38 Mentor Begins Phase-I Clinical Trial on Botulinum ...and more »

Changing facesExpress Pharma, India - 2 hours agoSpeaking on company's investment plans, Narayanan says that Allergan has committed approximately $800 million in Botox research and clinical development. ...